Rulemaking action by the Iowa Board of Pharmacy has been published in the Iowa Administrative Bulletin as follows:
Notice of Intended Action
ARC 5155C has been published as a Notice of Intended Action to amend Chapter 10, “Controlled Substances”
-
The proposed amendments:
-
Temporarily place into the Iowa CSA five substances
-
One fentanyl precursor into Schedule II
-
One FDA-approved insomnia treatment into Schedule IV
-
One FDA-approved seizure treatment into Schedule V
-
Two chemicals used in the manufacture of illicit fentanyl as precursor substances
-
-
Remove the names of prior substances temporarily scheduled by rule following the permanent schedule of the substances via the passage of Senate File 2119
-
Amend subrule 10.38(3) to incorporate language from Senate File 2119
-
Rescind 10.30(2), paragraph “g”, in response to Section 1 of Senate File 2357 which removes the requirement that the name of a supervising physician is required to be included on a prescription issued by a physician assistant.
-
-
Comments may be submitted no later than 4:30pm on September 15, 2020 through the link above.